592 related articles for article (PubMed ID: 18695082)
1. Overweight, obesity, and the risk of recurrent venous thromboembolism.
Eichinger S; Hron G; Bialonczyk C; Hirschl M; Minar E; Wagner O; Heinze G; Kyrle PA
Arch Intern Med; 2008 Aug; 168(15):1678-83. PubMed ID: 18695082
[TBL] [Abstract][Full Text] [Related]
2. High plasma levels of factor VIII and the risk of recurrent venous thromboembolism.
Kyrle PA; Minar E; Hirschl M; Bialonczyk C; Stain M; Schneider B; Weltermann A; Speiser W; Lechner K; Eichinger S
N Engl J Med; 2000 Aug; 343(7):457-62. PubMed ID: 10950667
[TBL] [Abstract][Full Text] [Related]
3. Symptomatic pulmonary embolism and the risk of recurrent venous thromboembolism.
Eichinger S; Weltermann A; Minar E; Stain M; Schönauer V; Schneider B; Kyrle PA
Arch Intern Med; 2004 Jan; 164(1):92-6. PubMed ID: 14718328
[TBL] [Abstract][Full Text] [Related]
4. Family history for venous thromboembolism and the risk for recurrence.
Hron G; Eichinger S; Weltermann A; Minar E; Bialonczyk C; Hirschl M; Stain M; Gartner V; Kyrle PA
Am J Med; 2006 Jan; 119(1):50-3. PubMed ID: 16431184
[TBL] [Abstract][Full Text] [Related]
5. The risk of recurrent venous thromboembolism in patients with and without factor V Leiden.
Eichinger S; Pabinger I; Stümpflen A; Hirschl M; Bialonczyk C; Schneider B; Mannhalter C; Minar E; Lechner K; Kyrle PA
Thromb Haemost; 1997 Apr; 77(4):624-8. PubMed ID: 9134632
[TBL] [Abstract][Full Text] [Related]
6. Risk assessment of recurrence in patients with unprovoked deep vein thrombosis or pulmonary embolism: the Vienna prediction model.
Eichinger S; Heinze G; Jandeck LM; Kyrle PA
Circulation; 2010 Apr; 121(14):1630-6. PubMed ID: 20351233
[TBL] [Abstract][Full Text] [Related]
7. Risk of venous thrombosis: obesity and its joint effect with oral contraceptive use and prothrombotic mutations.
Pomp ER; le Cessie S; Rosendaal FR; Doggen CJ
Br J Haematol; 2007 Oct; 139(2):289-96. PubMed ID: 17897305
[TBL] [Abstract][Full Text] [Related]
8. Inflammatory bowel disease is a risk factor for recurrent venous thromboembolism.
Novacek G; Weltermann A; Sobala A; Tilg H; Petritsch W; Reinisch W; Mayer A; Haas T; Kaser A; Feichtenschlager T; Fuchssteiner H; Knoflach P; Vogelsang H; Miehsler W; Platzer R; Tillinger W; Jaritz B; Schmid A; Blaha B; Dejaco C; Eichinger S
Gastroenterology; 2010 Sep; 139(3):779-87, 787.e1. PubMed ID: 20546736
[TBL] [Abstract][Full Text] [Related]
9. High long-term absolute risk of recurrent venous thromboembolism in patients with hereditary deficiencies of protein S, protein C or antithrombin.
Brouwer JL; Lijfering WM; Ten Kate MK; Kluin-Nelemans HC; Veeger NJ; van der Meer J
Thromb Haemost; 2009 Jan; 101(1):93-9. PubMed ID: 19132194
[TBL] [Abstract][Full Text] [Related]
10. High plasma concentration of factor VIIIc is a major risk factor for venous thromboembolism.
Kraaijenhagen RA; in't Anker PS; Koopman MM; Reitsma PH; Prins MH; van den Ende A; Büller HR
Thromb Haemost; 2000 Jan; 83(1):5-9. PubMed ID: 10669145
[TBL] [Abstract][Full Text] [Related]
11. [Impact of body weight on the risk of venous thromboembolism].
Petrovic T; Koller T; Payer J
Vnitr Lek; 2009 Feb; 55(2):106-10. PubMed ID: 19348391
[TBL] [Abstract][Full Text] [Related]
12. Excess weight at time of presentation of myocardial infarction is associated with lower initial mortality risks but higher long-term risks including recurrent re-infarction and cardiac death.
Nigam A; Wright RS; Allison TG; Williams BA; Kopecky SL; Reeder GS; Murphy JG; Jaffe AS
Int J Cardiol; 2006 Jun; 110(2):153-9. PubMed ID: 16043245
[TBL] [Abstract][Full Text] [Related]
13. The risk of early recurrent venous thromboembolism after oral anticoagulant therapy in patients with the G20210A transition in the prothrombin gene.
Eichinger S; Minar E; Hirschl M; Bialonczyk C; Stain M; Mannhalter C; Stümpflen A; Schneider B; Lechner K; Kyrle PA
Thromb Haemost; 1999 Jan; 81(1):14-7. PubMed ID: 10348706
[TBL] [Abstract][Full Text] [Related]
14. Prognostic factors for recurrence of venous thromboembolism (VTE) or bleeding during long-term secondary prevention of VTE with ximelagatran.
Eriksson H; Lundström T; Wåhlander K; Clason SB; Schulman S;
Thromb Haemost; 2005 Sep; 94(3):522-7. PubMed ID: 16268466
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of fixed low-dose dalteparin in preventing venous thromboembolism among obese or elderly hospitalized patients: a subgroup analysis of the PREVENT trial.
Kucher N; Leizorovicz A; Vaitkus PT; Cohen AT; Turpie AG; Olsson CG; Goldhaber SZ
Arch Intern Med; 2005 Feb; 165(3):341-5. PubMed ID: 15710801
[TBL] [Abstract][Full Text] [Related]
16. Body mass index, waist circumference, and waist-hip ratio on the risk of total and type-specific stroke.
Hu G; Tuomilehto J; Silventoinen K; Sarti C; Männistö S; Jousilahti P
Arch Intern Med; 2007 Jul; 167(13):1420-7. PubMed ID: 17620537
[TBL] [Abstract][Full Text] [Related]
17. The risk of recurrent venous thromboembolism in patients with an Arg506-->Gln mutation in the gene for factor V (factor V Leiden).
Simioni P; Prandoni P; Lensing AW; Scudeller A; Sardella C; Prins MH; Villalta S; Dazzi F; Girolami A
N Engl J Med; 1997 Feb; 336(6):399-403. PubMed ID: 9010145
[TBL] [Abstract][Full Text] [Related]
18. Superficial thrombophlebitis and risk for recurrent venous thromboembolism.
Schönauer V; Kyrle PA; Weltermann A; Minar E; Bialonczyk C; Hirschl M; Quehenberger P; Schneider B; Partsch H; Eichinger S
J Vasc Surg; 2003 Apr; 37(4):834-8. PubMed ID: 12663985
[TBL] [Abstract][Full Text] [Related]
19. Circulating P-selectin and the risk of recurrent venous thromboembolism.
Kyrle PA; Hron G; Eichinger S; Wagner O
Thromb Haemost; 2007 Jun; 97(6):880-3. PubMed ID: 17549288
[TBL] [Abstract][Full Text] [Related]
20. Coexistence of factor V Leiden and Factor II A20210 mutations and recurrent venous thromboembolism.
Margaglione M; D'Andrea G; Colaizzo D; Cappucci G; del Popolo A; Brancaccio V; Ciampa A; Grandone E; Di Minno G
Thromb Haemost; 1999 Dec; 82(6):1583-7. PubMed ID: 10613638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
